Speech apraxia
Gene: ANK2
In-house CAS proband now published (paternal, frameshift) (PMID: 41530369). Validated diagnostic finding from VCGS clinical NATA pipeline.Created: 20 May 2026, 3:46 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Neurodevelopmental disorder (MONDO:0700092), ANK2-related.
Publications
An in-house (as yet unpublished) CAS proband with a pathogenic variant.
Sources: Expert list, Expert ReviewCreated: 12 Sep 2024, 6:12 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Cardiac arrhythmia, ankyrin-B-related, MIM# 600919; Long QT syndrome 4, MIM# 600919; Neurodevelopmental disorder (MONDO:0700092), ANK2-related
Publications
Gene: ank2 has been classified as Red List (Low Evidence).
Phenotypes for gene: ANK2 were changed from Cardiac arrhythmia, ankyrin-B-relatedNeurodevelopmental disorder (MONDO:0700092), gene-related to Neurodevelopmental disorder (MONDO:0700092), gene-related
Gene: ank2 has been classified as Red List (Low Evidence).
gene: ANK2 was added gene: ANK2 was added to Speech apraxia. Sources: Expert Review Mode of inheritance for gene: ANK2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: ANK2 were set to 37195288 Phenotypes for gene: ANK2 were set to Cardiac arrhythmia, ankyrin-B-relatedNeurodevelopmental disorder (MONDO:0700092), gene-related Review for gene: ANK2 was set to RED